IP Library Granted Patent US 9,333,111
Granted Patent B2
US 9,333,111 · App. 13/758,188 · Granted May 10, 2016

Fundus bumper mechanical reference for easier mechanism deployment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,333,111
App. No.
13/758,188
Granted
May 10, 2016
Kind
B2
Abstract

Intrauterine devices and methods for facilitating deployment thereof using a bumper are disclosed. In one embodiment, an intrauterine device comprises a structure including a first central support member and a deployment mechanism coupled to the first central support member. The intrauterine device further comprises a bumper positioned at a distal end of a second central support member and at a more distal position relative to a distal end of the structure so as to prevent the distal end of the structure from contacting the fundus of the uterus of a patient during deployment of the deployment mechanism. In another embodiment, the intrauterine device comprises a bumper coupled to the deployment mechanism and configured to move from a more distal to a more proximal position relative to a distal end of the structure.

Claims (20)

1. An intrauterine ablation device, comprising:

an elongate tubular member configured for transcervical insertion;

an elongate central member slidably disposed within the elongate tubular member, the elongate central member comprising a distal bumper; and

an energy applicator operatively coupled to the elongate tubular member, the energy applicator comprising a tissue contacting member, and an expandable-collapsible support structure underlying the tissue contacting member, the expandable-collapsible support structure comprising a first flexure having a first flexure distal tip and a second flexure having a second flexure distal tip, wherein the first and second flexures are adjustable between a collapsed configuration, in which the first and second flexure distal tips are closely apposed to the elongate central member and disposed proximally of and adjacent to the distal bumper, and an expanded configuration in which the first and second flexure distal tips extend laterally in opposite directions away from the elongate central member and the distal bumper;

wherein the distal bumper has an insertion profile at least as large as an insertion profile of the expandable-collapsible support structure in the collapsed configuration,

wherein the distal bumper is distal to the first and second flexure distal tips in the collapsed configuration and is configured to contact a fundal wall of the uterus upon distal advancement of the elongate central member relative to the elongate tubular member within the uterus to thereby prevent the first and second flexure distal tips from engaging the fundal wall during transition of the expandable-collapsible support structure from the collapsed configuration to the expanded configuration, and

wherein the elongate central member and the expandable-collapsible support structure are configured to move relative to each other along a longitudinal direction of the elongate central member so as to change a position of the distal bumper relative to the first and second flexure distal tips.

2. The intrauterine ablation device of claim 1 , wherein the distal bumper is further configured to move to a retracted position when the expandable-collapsible support structure is in the expanded configuration, so that the distal bumper in the retracted position is disposed proximally of the first and second flexure distal tips.

3. The intrauterine ablation device of claim 1 , wherein the tissue contacting member of the energy applicator and the distal bumper of the elongate central member are configured to deliver ablation energy to the tissue of the uterus.

4. The intrauterine ablation device of claim 3 , wherein the distal bumper comprises an electrically conductive material, including one of a porous material, a hydrophilic material, a conductive polymer and/or a material infused with an electrically conductive particulate.

5. An intrauterine ablation device, comprising:

an elongate tubular member configured for transcervical insertion;

an elongate central member coaxially and slidably disposed within the tubular member;

an energy applicator operatively coupled to the elongate tubular member, the energy applicator comprising a tissue contacting member and an expandable-collapsible support structure underlying the tissue contacting member, the expandable-collapsible support structure comprising a first flexure having a first flexure distal tip, and a second flexure having a second flexure distal tip, with the elongate central member extending between the first flexure and the second flexure, wherein the first and second flexures are adjustable between a collapsed configuration, in which the first and second flexure distal tips are closely apposed to the elongate central member, and an expanded configuration, in which the first and second flexure distal tips extend laterally in opposite directions away from the elongate central member; and

an elongate distal bumper having a first end coupled to the first flexure and a second end coupled to the second flexure, so that when the first and second flexures are in the collapsed configuration, the elongate distal bumper is configured to arc, thereby forming an arch between, and extend distally from, the first and second flexure distal tips, and when the first and second flexures are in the expanded configuration, the elongate distal bumper is configured to straighten between the first and second flexure distal tips,

wherein the distal bumper is configured to contact a fundal wall of the uterus upon distal advancement of the elongate central member relative to the elongate tubular member within the uterus to thereby prevent the first and second flexure distal tips from engaging the fundal wall during transition of the expandable-collapsible support structure from the collapsed configuration to the expanded configuration.

6. The intrauterine ablation device of claim 5 , wherein the elongate distal bumper comprises a flexible ribbon and/or a thin flexible membrane configured to contact a fundal wall of a uterus.

7. The intrauterine ablation device of claim 5 , wherein the elongate distal bumper is configured to conform to a fundal wall of a uterus, and wherein the elongate distal bumper extends transversely between the first and second flexure distal tips of the expandable-collapsible support structure in the expanded configuration.

8. The intrauterine ablation device of claim 5 , wherein the elongate distal bumper comprises an electrically conductive material, including one of a porous material, a hydrophilic material, a conductive polymer and/or a material infused with an electrically conductive particulate.

9. The intrauterine ablation device of claim 5 , wherein the elongate distal bumper is positioned distally of the energy applicator.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE R/F 030147 0812 Recorded Jul 17, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 036127/0315 →
SECURITY AGREEMENT Recorded Apr 4, 2013
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED; DIRECT RADIOGRAPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 030147/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2013
From: KOCHEM, THOMAS C.; BEAUDET, DANIEL A.
To: HOLOGIC, INC.
Reel/Frame 029829/0162 →